SYNACT.ST | SynAct Pharma AB Annual & Quarterly Balance

Annual Balance Sheets

(In SEK)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	228.01 Million	142.59 Million	38.36 Million	21.59 Million	23.81 Million	14.02 Million
Total Current Assets	75.06 Million	140.23 Million	34.91 Million	21.32 Million	8.45 Million	13.13 Million
Cash And Short Term Investments	62.39 Million	108.24 Million	23.99 Million	14.54 Million	3.55 Million	7.11 Million
Cash and Cash Equivalents	62.39 Million	108.24 Million	23.99 Million	14.54 Million	3.55 Million	7.11 Million
Short Term Investments	-	180 Thousand	-	-208 Thousand	-	-
Net Receivables	12.4 Million	14.69 Million	10.67 Million	6.46 Million	4.89 Million	6.01 Million
Inventory	-	-	246 Thousand	321 Thousand	-22.22 Thousand	-6.01 Million
Other Current Assets	257 Thousand	17.29 Million	1000.00	-1000.00	22.22 Thousand	6.01 Million
Total Non-Current Assets	152.95 Million	2.36 Million	3.45 Million	264 Thousand	15.36 Million	894.03 Thousand
Net PPE	660 Thousand	2.09 Million	3.17 Million	-	-	-
Good Will And Intangible Assets	152.15 Million	-	-	-	1.31 Million	769.34 Thousand
Good Will	-	-	-	-	-	-
Intangible Assets	152.15 Million	-	-	-	1.31 Million	769.34 Thousand
Long-Term Investments	139 Thousand	90 Thousand	75 Thousand	264 Thousand	129.1 Thousand	124.68 Thousand
Tax Assets	-152.15 Million	-	-	-	-	-
Other Non Current Assets	152.16 Million	180 Thousand	199 Thousand	-	13.91 Million	-
Other Assets	-0.00	-	-	-	-	-
Total Liabilities	51.83 Million	16.07 Million	17.5 Million	5.72 Million	10.31 Million	3.71 Million
Total Current Liabilities	24.93 Million	15.01 Million	15.39 Million	5.72 Million	10.31 Million	3.71 Million
Account Payables	9.67 Million	4.72 Million	4.25 Million	2.77 Million	5.46 Million	3.23 Million
Tax Payables	3.68 Million	1.54 Million	1.61 Million	1.61 Million	-	-
Short Term Debt	579 Thousand	1 Million	979 Thousand	-	-	-
Deferred Revenue	-	-	9.5 Million	-	-	-
Other Current Liabilities	14.69 Million	9.29 Million	654 Thousand	2.95 Million	4.84 Million	484.14 Thousand
Total Non Current Liabilities	26.89 Million	1.06 Million	2.11 Million	-1000.00	1.00	3.23 Million
Long-Term Debt	58 Thousand	1.06 Million	2.11 Million	-	-	-
Deferred Revenue Non Current	-	-	-	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	8.82 Million	-1000.00	-	-1000.00	-	3.23 Million
Other Liabilities	-	-	-	1000.00	-	-3.23 Million
Total Equity	176.18 Million	126.52 Million	20.86 Million	15.86 Million	13.5 Million	10.31 Million
Stock Holders Equity	176.18 Million	126.52 Million	20.86 Million	15.86 Million	13.5 Million	10.31 Million
Common Stock	4.44 Million	3.7 Million	3.25 Million	3.05 Million	2.09 Million	1.83 Million
Retained Earnings	-490.6 Million	-274.79 Million	-175.58 Million	-106.28 Million	-79.72 Thousand	-55.23 Million
Accumulated other comprehensive income	15.76 Million	2.76 Million	-399 Thousand	-304.00	-78.14 Million	-46.02 Million
Common Stock Equity	176.18 Million	126.52 Million	20.86 Million	15.86 Million	13.5 Million	10.31 Million
Capital Lease Obligation	58 Thousand	2.06 Million	3.08 Million	-	-	-
Total Investments	139 Thousand	270 Thousand	75 Thousand	56 Thousand	129.1 Thousand	124.68 Thousand
Total Debt	637 Thousand	2.06 Million	3.08 Million	-	-	-
Net Debt	-61.75 Million	-106.18 Million	-20.9 Million	-14.54 Million	-3.55 Million	-7.11 Million

Breakdown	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 FY	2023 Q3
Total Assets	217.13 Million	241.05 Million	213.35 Million	228.01 Million	228.01 Million	275.92 Million
Total Current Assets	63.53 Million	89.72 Million	62.82 Million	75.06 Million	75.06 Million	48.53 Million
Cash And Short Term Investments	38.48 Million	62.79 Million	51.55 Million	62.39 Million	62.39 Million	28.87 Million
Cash and Cash Equivalents	38.48 Million	62.79 Million	51.55 Million	62.39 Million	62.39 Million	28.87 Million
Short Term Investments	-	-	-	-	-	-
Net Receivables	17.5 Million	13.14 Million	10.79 Million	12.4 Million	12.4 Million	18.97 Million
Inventory	-	-	-	-	-	690 Thousand
Other Current Assets	-	13.77 Million	484 Thousand	257 Thousand	257 Thousand	-1000.00
Total Non-Current Assets	153.59 Million	151.32 Million	150.52 Million	152.95 Million	152.95 Million	227.38 Million
Net PPE	1.43 Million	1.46 Million	529 Thousand	660 Thousand	660 Thousand	825 Thousand
Good Will And Intangible Assets	152.01 Million	149.72 Million	149.85 Million	152.15 Million	152.15 Million	226.41 Million
Good Will	-	-	-	-	-	75.15 Million
Intangible Assets	152.01 Million	149.72 Million	149.85 Million	152.15 Million	152.15 Million	155.46 Thousand
Long-Term Investments	142 Thousand	142 Thousand	144 Thousand	139 Thousand	139 Thousand	144 Thousand
Tax Assets	-	-149.72 Million	-149.85 Million	-152.15 Million	-152.15 Million	-144 Thousand
Other Non Current Assets	-	149.72 Million	149.85 Million	152.16 Million	152.16 Million	144 Thousand
Other Assets	-	1.00	-	-	-	-
Total Liabilities	47.96 Million	54.06 Million	61.06 Million	51.83 Million	51.83 Million	66.01 Million
Total Current Liabilities	16.35 Million	21.12 Million	27.18 Million	24.93 Million	24.93 Million	36.99 Million
Account Payables	6.45 Million	5.69 Million	10.82 Million	9.67 Million	9.67 Million	8.32 Million
Tax Payables	-	-	-	3.68 Million	3.68 Million	-
Short Term Debt	498 Thousand	454 Thousand	474 Thousand	579 Thousand	579 Thousand	626 Thousand
Deferred Revenue	-	-	-	-	-	22.93 Million
Other Current Liabilities	9.4 Million	14.97 Million	15.88 Million	14.69 Million	14.69 Million	5.11 Million
Total Non Current Liabilities	31.61 Million	32.93 Million	33.87 Million	26.89 Million	26.89 Million	29.01 Million
Long-Term Debt	-	982 Thousand	24 Thousand	58 Thousand	58 Thousand	180 Thousand
Deferred Revenue Non Current	-	-	-	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	13.61 Million	14.22 Million	16.1 Million	8.82 Million	8.82 Million	10.92 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	169.16 Million	186.99 Million	152.29 Million	176.18 Million	176.18 Million	209.91 Million
Stock Holders Equity	169.16 Million	186.99 Million	152.29 Million	176.18 Million	176.18 Million	209.91 Million
Common Stock	5.16 Million	5.16 Million	4.44 Million	4.44 Million	4.44 Million	3.97 Million
Retained Earnings	-554.62 Million	-534.13 Million	-515.5 Million	-490.6 Million	-490.6 Million	-400.05 Million
Accumulated other comprehensive income	15.82 Million	13.87 Million	14.16 Million	15.76 Million	15.76 Million	16.61 Million
Common Stock Equity	169.16 Million	186.99 Million	152.29 Million	176.18 Million	176.18 Million	209.91 Million
Capital Lease Obligation	-	982 Thousand	24 Thousand	58 Thousand	58 Thousand	806 Thousand
Total Investments	142 Thousand	142 Thousand	144 Thousand	139 Thousand	139 Thousand	144 Thousand
Total Debt	498 Thousand	1.43 Million	498 Thousand	637 Thousand	637 Thousand	806 Thousand
Net Debt	-37.99 Million	-61.36 Million	-51.05 Million	-61.75 Million	-61.75 Million	-28.07 Million

Balance Sheet Charts

Railcare Group AB (publ)

RAIL

Full Analysis

Annual Balance Sheets
Annexin Pharmaceuticals AB (publ)

ANNX

Full Analysis

Annual Balance Sheets
Allarity Therapeutics, Inc.

ALLR

Full Analysis

Annual Balance Sheets
Algernon Pharmaceuticals Inc.

AGNPF

Full Analysis

Annual Balance Sheets
Wallenstam AB (publ)

WALL-B

Full Analysis

Annual Balance Sheets
Substrate Artificial Inteligence, S.A.

SAI

Full Analysis

Annual Balance Sheets

Global Stocks Search

SynAct Pharma AB (SYNACT.ST)

Annual Balance Sheets

Balance Sheet Charts

Railcare Group AB (publ)

Annexin Pharmaceuticals AB (publ)

Allarity Therapeutics, Inc.

Algernon Pharmaceuticals Inc.

Wallenstam AB (publ)

Substrate Artificial Inteligence, S.A.